Differential inhibition of stress-induced adrenocortical responses by 5-HT1A agonists and by 5-HT2 and 5-HT3 antagonists

D SaphierJ E Welch


The present studies were designed to determine the effects of 5-HT1A receptor agonists and 5-HT2A/2C and 5-HT3 antagonists on adrenocortical responses to a variety of stress paradigms in conscious male rats. The following stressors were examined: acoustic stress (105 dB for 2 min); foot shock (0.2 mA, five shocks over 5 min); conditioned fear (animals placed in the foot shock chamber for 5 min, 24 h after foot shock); restraint (Plexiglas restrainer for 5 min); injection of recombinant human interleukin-1 alpha (IL-1, 20 micrograms/kg, IP); injection of cocaine hydrochloride (20 mg/kg, IP). Drug treatments consisted of intracerebroventricular (ICV) or intraperitoneal (IP) injections of the 5-HT1A agonists, 8-OH-DPAT and ipsapirone (0.1 pmol, ICV), the 5-HT2A/2C antagonist, ketanserin (2 mumol/kg, IP), and the 5-HT3 antagonist, MDL-72222 (20 nmol, ICV). The plasma corticosterone (CS) responses to foot shock and restraint stress were not affected by any of the serotonergic drugs tested. The 5-HT1A agonist, 8-OH-DPAT, was able to attenuate the adrenocortical responses to acoustic stimulation, conditioned fear, IL-1 alpha, and cocaine administration, with ipsapirone also being effective in reducing the responses to acoustic stimula...Continue Reading


Oct 28, 1977·Annals of the New York Academy of Sciences·J Vernikos-DanellisJ D Barchas
Jan 1, 1991·Psychopharmacology·A J Lazosky, D R Britton
Jan 1, 1989·Psychoneuroendocrinology·D Saphier
Nov 1, 1989·Neuropharmacology·D Saphier, S Feldman
May 1, 1986·Pharmacology, Biochemistry, and Behavior·C R Gardner
Feb 1, 1987·Journal of Clinical Psychopharmacology·I CsanalosiK Rickels
Apr 1, 1988·British Journal of Pharmacology·B J JonesM B Tyers
Apr 1, 1988·The Journal of Pharmacy and Pharmacology·B CostallR J Naylor
May 20, 1985·European Journal of Pharmacology·G A SmytheM V Nicholson
Jan 1, 1987·Psychopharmacology·M A Critchley, S L Handley
Mar 29, 1974·Nature·P A BergerJ Vernikos-Danellis
May 1, 1974·The Journal of Clinical Endocrinology and Metabolism·J W PlonkJ M Feldman
Sep 1, 1969·European Journal of Pharmacology·S B Ross, A L Renyi
Dec 1, 1967·European Journal of Pharmacology·S B Ross, A L Renyi
Jul 1, 1983·Journal of Steroid Biochemistry·A SzafarczykI Assenmacher

❮ Previous
Next ❯


Jun 1, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Donn A Simmons, Patricia A Broderick
Feb 26, 2003·European Journal of Pharmacology·Gonzalo A Carrasco, Louis D Van de Kar
Nov 14, 1997·Neuroscience and Biobehavioral Reviews·L Uphouse
May 6, 1998·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·K AntoniouA Sfikakis
Jan 10, 2001·Canadian Journal of Physiology and Pharmacology·V ContesseH Vaudry
Nov 7, 1998·Brain Research·H JørgensenJ Warberg
May 8, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Anne-Cécile PetitEmmanuelle Corruble
Nov 30, 2014·Molecular and Cellular Endocrinology·H LefebvreE Louiset
Feb 24, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Hsiang-Yi TsaiYen Kuang Yang
Jan 12, 1999·Frontiers in Neuroendocrinology·L D Van de Kar, M L Blair
Nov 14, 2008·Stress : the International Journal on the Biology of Stress·Karen L SmithDavid P Finn
Jul 16, 2005·Stress : the International Journal on the Biology of Stress·Seema Bhatnagar, Courtenay Vining
Aug 2, 2020·The Journal of Experimental Biology·Constance PierreSylvie Rétaux

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.